Francken AB - Search Results

1

Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study): An International Phase III Randomized Clinical Trial.

Moncrieff MD, Bastiaannet E, Underwood B, Francken AB, Garioch J, Damude S, Heaton M, Deckers EA, Patel N, Hoekstra-Weebers JE, Hoekstra HJ. Moncrieff MD, et al. Among authors: francken ab. Ann Surg. 2022 Oct 1;276(4):e208-e216. doi: 10.1097/SLA.0000000000005621. Epub 2022 Jul 22. Ann Surg. 2022. PMID: 35866644 Clinical Trial.

2

Follow-up in patients with localised primary cutaneous melanoma.

Francken AB, Bastiaannet E, Hoekstra HJ. Francken AB, et al. Lancet Oncol. 2005 Aug;6(8):608-21. doi: 10.1016/S1470-2045(05)70283-7. Lancet Oncol. 2005. PMID: 16054572 Review.

3

Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.

Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Francken AB, et al. Ann Surg Oncol. 2007 Jun;14(6):1924-33. doi: 10.1245/s10434-007-9347-2. Epub 2007 Mar 15. Ann Surg Oncol. 2007. PMID: 17357855

4

Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.

Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF. Francken AB, et al. Ann Surg Oncol. 2008 May;15(5):1476-84. doi: 10.1245/s10434-007-9717-9. Epub 2008 Jan 15. Ann Surg Oncol. 2008. PMID: 18196345

5

[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].

Francken AB, Thompson JF, Bastiaannet E, Hoekstra HJ. Francken AB, et al. Ned Tijdschr Geneeskd. 2008 Mar 8;152(10):557-62. Ned Tijdschr Geneeskd. 2008. PMID: 18402322 Dutch.

6

Follow-up schedules after treatment for malignant melanoma.

Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF. Francken AB, et al. Br J Surg. 2008 Nov;95(11):1401-7. doi: 10.1002/bjs.6347. Br J Surg. 2008. PMID: 18844268

7

Follow-up of melanoma patients: the need for evidence-based protocols.

Francken AB, Hoekstra HJ. Francken AB, et al. Ann Surg Oncol. 2009 Apr;16(4):804-5. doi: 10.1245/s10434-009-0318-7. Epub 2009 Feb 3. Ann Surg Oncol. 2009. PMID: 19189190 Free article. No abstract available.

8

Perception of burden experienced during diagnostic tests by melanoma patients with lymph node metastases.

Bastiaannet E, Hoekstra-Weebers JE, Francken AB, Jager PL, van der Jagt EJ, Hoekstra HJ. Bastiaannet E, et al. Among authors: francken ab. Melanoma Res. 2009 Feb;19(1):36-41. doi: 10.1097/CMR.0b013e32831993b7. Melanoma Res. 2009. PMID: 19430404 Free article.

9

Is GP-led follow-up feasible?

Francken AB, Hoekstra-Weebers JW, Hoekstra HJ. Francken AB, et al. Br J Cancer. 2010 May 11;102(10):1445-6. doi: 10.1038/sj.bjc.6605667. Br J Cancer. 2010. PMID: 20461088 Free PMC article. No abstract available.

10

Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.

Kruijff S, Bastiaannet E, Francken AB, Schaapveld M, van der Aa M, Hoekstra HJ. Kruijff S, et al. Among authors: francken ab. Br J Cancer. 2012 Jul 24;107(3):570-4. doi: 10.1038/bjc.2012.255. Epub 2012 Jun 19. Br J Cancer. 2012. PMID: 22713665 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page